These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18673184)

  • 1. Role of the autonomic nervous system and neuropeptides in the development of obesity in humans: targets for therapy?
    Greenfield JR; Campbell LV
    Curr Pharm Des; 2008; 14(18):1815-20. PubMed ID: 18673184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic system activity in obesity and metabolic syndrome.
    Tentolouris N; Liatis S; Katsilambros N
    Ann N Y Acad Sci; 2006 Nov; 1083():129-52. PubMed ID: 17148737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into sympathetic regulation of glucose and fat metabolism.
    Nonogaki K
    Diabetologia; 2000 May; 43(5):533-49. PubMed ID: 10855527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?
    Lambert EA; Straznicky NE; Dixon JB; Lambert GW
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H244-58. PubMed ID: 25980020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the effect of weight loss on cardiovascular autonomic function.
    Maser RE; Lenhard MJ
    Curr Diabetes Rev; 2007 Aug; 3(3):204-11. PubMed ID: 18220673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central role of the adipocyte in the metabolic syndrome.
    Bergman RN; Van Citters GW; Mittelman SD; Dea MK; Hamilton-Wessler M; Kim SP; Ellmerer M
    J Investig Med; 2001 Jan; 49(1):119-26. PubMed ID: 11217141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies.
    Lips MA; de Groot GH; De Kam M; Berends FJ; Wiezer R; Van Wagensveld BA; Swank DJ; Luijten A; Pijl H; Burggraaf J
    Eur J Endocrinol; 2013 Oct; 169(4):383-90. PubMed ID: 23847327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global epidemic of obesity: are we becoming more sympathetic?
    Davy KP
    Curr Hypertens Rep; 2004 Jun; 6(3):241-6. PubMed ID: 15128479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
    Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
    Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Richards K; Dixon JB; Schlaich MP; Lambert EA
    Metabolism; 2015 Jul; 64(7):797-803. PubMed ID: 25827058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine deregulation of food intake, adipose tissue and the gastrointestinal system in obesity and metabolic syndrome.
    Garruti G; Cotecchia S; Giampetruzzi F; Giorgino F; Giorgino R
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):193-8. PubMed ID: 18568142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic nervous system behavior in human obesity.
    Davy KP; Orr JS
    Neurosci Biobehav Rev; 2009 Feb; 33(2):116-24. PubMed ID: 18602694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glibenclamide treatment blocks metabolic dysfunctions and improves vagal activity in monosodium glutamate-obese male rats.
    Franco CCS; Prates KV; Previate C; Moraes AMP; Matiusso CCI; Miranda RA; de Oliveira JC; Tófolo LP; Martins IP; Barella LF; Ribeiro TA; Malta A; Pavanello A; Francisco FA; Gomes RM; Alves VS; Moreira VM; Rigo KP; Almeida DL; de Sant Anna JR; Prado MAAC; Mathias PCF
    Endocrine; 2017 May; 56(2):346-356. PubMed ID: 28233096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sympathetic outflow to adipose depots is required for visceral fat loss in response to calorie restriction.
    Sipe LM; Yang C; Ephrem J; Garren E; Hirsh J; Deppmann CD
    Nutr Diabetes; 2017 Apr; 7(4):e260. PubMed ID: 28394360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic and genetic obesity: an appraisal of the autonomic hypothesis and the endocrine hypothesis.
    Bray GA
    Int J Obes; 1984; 8 Suppl 1():119-37. PubMed ID: 6398803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.